GeoVax Labs Inc.

GOVX | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.48

-$0.03 (-5.29%)

At close: Sep 4, 2026, 3:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-5.29%

(1D)

Rating

Updated: Jul 31, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $3.56M

1D Range

0.48 0.53

52W Range

0.48 19

Valuation (TTM)

PE -0.03

PB 2.02

EV/EBITDA -0.04

Valuation (NTM)

Forward PE 0.01

Forward PEG N/A

Price Target $100

Cash Flow

FCF Yield -516.1%

SBC Adj. FCF Yield -534.7%

SBC Impact -3.6%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y 212.6% | 6.4%

Dil EPS 3Y | 5Y 27.9% | 4.5%

FCF 3Y | 5Y -4.1% | -127.9%

Returns

ROA -439.9%

ROE -743.7%

ROIC -985.2%

Financial Health

Net Cash

$2.99M

Current Ratio 1.54

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various...

Sector Healthcare

Industry Biotechnology

Employees 19

IPO Date Sep 24, 2020

Website www.geovax.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$100

Upside

+20603.93%

Buy (0)

Hold (1)

Sell (0)

Analyst Details ➞